| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| BridgeBio Pharma, Inc. | Director | Common Stock | 16,991 | $1,082,695 | $63.72 | 06 Nov 2025 | Direct |
| BridgeBio Pharma, Inc. | Director | Stock Option (Right to Buy) | 30,523 | 06 Nov 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| BBIO | BridgeBio Pharma, Inc. | 06 Nov 2025 | 3 | -$1,774,275 | 4 | Director | 07 Nov 2025, 18:03 |
| BBIO | BridgeBio Pharma, Inc. | 20 Jun 2025 | 2 | $0 | 4 | Director | 24 Jun 2025, 19:06 |
| BBIO | BridgeBio Pharma, Inc. | 21 Jun 2024 | 1 | $0 | 4 | Director | 25 Jun 2024, 17:36 |
| BBIO | BridgeBio Pharma, Inc. | 21 Jun 2023 | 1 | $0 | 4 | Director | 23 Jun 2023, 16:17 |
| BBIO | BridgeBio Pharma, Inc. | 22 Jun 2022 | 1 | $0 | 4 | Director | 24 Jun 2022, 16:27 |
| BBIO | BridgeBio Pharma, Inc. | 28 Dec 2021 | 3 | +$148,343 | 4 | Director | 30 Dec 2021, 19:17 |
| BBIO | BridgeBio Pharma, Inc. | 17 Jun 2021 | 1 | $0 | 4 | Director | 22 Jun 2021, 19:15 |